ReviewExpert review of anticancer therapy2022

Treatment of small (T1mic, T1a, and T1b) node-negative HER2+ breast cancer - a review of current evidence for and against the use of anti-HER2 treatment regimens.

Kai Cc Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.